School of Medicine
Showing 2,521-2,540 of 12,892 Results
-
Scott L. Delp, Ph.D.
Director, Wu Tsai Human Performance Alliance at Stanford, James H. Clark Professor in the School of Engineering, Professor of Bioengineering and of Mechanical Engineering
Current Research and Scholarly InterestsExperimental and computational approaches to study human movement. Development of biomechanical models to analyze muscle function, study movement abnormalities, design medical products, and guide surgery. Imaging and health technology development. Discovering the principles of peak performance to advance human health. Human performance research. Wearable technologies, video motion capture, and machine learning to enable large-scale analysis.
-
Wendy DeMartini
Professor of Radiology (Breast Imaging)
On Leave from 09/08/2025 To 05/31/2026BioDr. Wendy DeMartini is a Professor in the Department of Radiology at Stanford University School of Medicine. She currently serves as the Associate Chair for Clinical Faculty Affairs in the Department of Radiology, and is the past Division Chief of Breast Imaging. Her work is focused upon high quality patient care, clinical research and education.
Dr. DeMartini completed her fellowship in Breast Imaging at the University of Washington School of Medicine in Seattle, Washington. She then served as Breast Imaging faculty at the University of Washington where she became Associate Professor and Associate Director of Clinical Services, and at the University of Wisconsin where she became Professor and Chief of Breast Imaging.
Dr. DeMartini has more than 100 research presentations, abstracts/publications, review articles or book chapters. Her research is directed toward the appropriate evidence-based use of imaging tests to optimize the detection and evaluation of breast cancer. She has served as an investigator on several studies of breast MRI funded by the National Cancer Institute and by the American College of Radiology Imaging Network (ACRIN). Particular research topics have included the development of a pilot tool for predicting the probability of malignancy of breast MRI lesions, assessment of the impact of background parenchymal enhancement (BPE) on breast MRI accuracy, and evaluation of utilization patterns of breast MRI and other emerging technologies. She also served as the Editor-in-Chief of the Journal of Breast Imaging from 2023 to 2024.
Dr. DeMartini is a highly sought-after educator. She lectures on a broad spectrum of breast imaging topics nationally and internationally, including in the Americas, Europe, Australasia and Africa. She is the past Co-Director of the American College of Radiology (ACR) Education Center Breast MRI with Biopsy Course. Dr. DeMartini is an active member of many professional organizations and committees, including in the Radiologic Society of North America, the American College of Radiology and the Society of Breast Imaging (SBI). She was elected as an SBI Fellow in 2009 and served as President of the SBI in 2017-2018. -
Utkan Demirci
Professor of Radiology (Diagnostic Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioDr. Utkan Demirci, UofM’99, Stanford’01’05’05, is a Professor of Radiology (with tenure) and of Electrical Engineering (by courtesy) at the Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, where he leads a productive researcher group. Utkan is a tenured professor at Stanford University School of Medicine. Prior to joining Stanford in 2014, he held the position of Associate Professor at the Brigham and Women’s Hospital-Harvard Medical School and also served at the Harvard-MIT Health Sciences and Technology division. Over the past decade, his research group has focused on the early detection of cancer and has made significant contributions to the development of microfluidic platforms for sorting rare cells and exosomes and point-of-care bio-sensing technologies.
Dr. Demirci leads a productive and impactful research group focused on addressing problems from the clinic with innovations including cell sorter for IVF, optical technologies for detecting viruses, portable point of care technologies for diagnostics in global health, smart robots in vivo, extracellular vesicle based early detection approaches for cancer. He is an elected fellow of the American Institute of Medical and Biological Engineering and The Academy for Radiology & Biomedical Imaging Research Distinguished Investigator.
He has published over 250 peer-reviewed articles, 300 abstracts and proceedings, 24 book chapters and editorials, and 7 edited books. He also serves on the editorial board of various journals. He is a serial academic entrepreneur and co-founded multiple successful companies. His patents are translated into broadly used biomedical products. Dr. Demirci's pioneering work in microfluidics and cell sorting has resulted in CE certified and FDA approved devices used in over 500,000 clinical cases serving patients globally. -
Megan DeMott, MD
Affiliate, Physician Assistant Studies
BioMegan DeMott, MD, earned dual Bachelor of Arts degrees in Biochemistry and Philosophy from Claremont McKenna College, graduating summa cum laude. She received her medical degree from Johns Hopkins University School of Medicine and completed residency training in Emergency Medicine at Henry Ford Hospital in Detroit, where she served as Chief Resident. She went on to complete a fellowship in Medical Toxicology at the University of California, San Diego.
For the past 15 years, Dr. DeMott has practiced at an indigent care hospital in Brawley, California, where she is dedicated to serving underserved populations. In addition to her clinical work, she mentors Stanford physician assistant students, fostering the next generation of healthcare providers. Her professional interests include medical toxicology, emergency care, and health equity in vulnerable communities. -
Stefania Demuro
Postdoctoral Scholar, Chemical and Systems Biology
BioStefania received her master’s degree in pharmaceutical chemistry from the University of Cagliari (Sardinia, Italy) and later moved to Philadelphia to conduct organic chemistry research at the University of Pennsylvania. Returning to Italy, she completed her Ph.D. in Medicinal Chemistry at the University of Bologna in collaboration with the Italian Institute of Technology, focusing on the development of first-in-class triple protein kinase inhibitors for the treatment of Alzheimer’s disease and related tauopathies (Prof. Andrea Cavalli).
As part of her doctoral training, Stefania spent time at UC San Diego in Prof. Carlo Ballatore’s group, where she developed novel microtubule stabilizers for the treatment of tauopathies.
Drawn to the interconnection between chemistry and biology, and after applying her medicinal chemistry expertise to research in diabetes and neuropathic pain at Stanford ChEM-H, she joined the Chen Lab to investigate the role of ALDH1B1 in tumorigenesis and HIPK4 as a target for male contraception. -
Lyn Denend
Academic Prog Prof Mgr, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector for Academic Programs, Stanford Biodesign
Lecturer, Stanford Medicine -
Boxiong Deng
Postdoctoral Scholar, Ophthalmology
BioBoxiong Currently is a postdoctoral fellow in Dr. Sui Wang's lab within Stanford University's Department of Ophathalmology, focusing on the interplay between retinal Müller glial cells and the vasculature in diabetic conditions.
